Back to Results
First PageMeta Content
Biology / Alternative complement pathway / Eculizumab / Complement control protein / Complement component 3 / C5-convertase / Complement component 5a / C3-convertase / C1-inhibitor / Complement system / Anatomy / Immune system


© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology REVIEW Complement-targeted therapeutics Daniel Ricklin & John D Lambris
Add to Reading List

Document Date: 2013-07-19 16:33:18

Open Document

File Size: 1,15 MB

Share Result on Facebook

City

Cincinnati / San Francisco / Boca Raton / ARC1905 Aptamer / Walport / Louisville / Rappaport / Cleveland / Richmond / Rockville / Totowa / Birmingham / New York / Cambridge / Copenhagen / Taligen / /

Company

BioCryst / Avant Immunotherapeutics Inc. Press / ODA / Archemix Corp. / CRC Press / Genentech / Inflazyme Pharmaceuticals / Millenium Pharmaceuticals / Procter & Gamble / AMD / Peptech Ltd. / C1r C1s Ab / Novo Nordisk / Marcel Dekker Inc. / IgG / Eyetech Pharmaceuticals / Potentia Pharmaceuticals / Enzon Pharmaceuticals / R.B. & Tsiftsoglou S.A. / Marchbank / Alexion Pharmaceuticals / Genmab A/S / Pfizer / Pharming Group N.V. / Humana Press / Davis A.E. / Lev Pharmaceuticals / Lev Pharma / /

Country

Netherlands / Canada / Australia / Denmark / United States / /

Currency

USD / /

/

Event

FDA Phase / Product Issues / Business Partnership / Reorganization / /

Facility

pipeline As / Laboratory Medicine / University of Pennsylvania / /

IndustryTerm

treatment / are usually referred to as site / pharmaceutical industry / biotechnology startups / cancer therapy / thioester / treatment for HAE and helps prevent severe disease / pharmaceutical pharmaceuticals / cebo / improved technology / biotechnology / pharmaceutical / treatment of chronic diseases / biotechnology field / /

MedicalCondition

HIV / multiple myeloma / post-ischemic myocardial inflammation / smallpox / follicular lymphoma / rheumatoid arthritis / chronic erythematosus uremic syndrome / macular degeneration / H. Hereditary angioedema / microbial infections / anaphylaxis / HAE / inhibition macular degeneration / injury / disorder / atypical hemolytic uremic syndrome / psoriasis / pathogenic complement activity Myocardial infarction / severe disease / inflammatory diseases / asthma / I/R injury / abdominal pain / neurodegenerative and infectious diseases / cancer / pancreatic and prostate cancer / stroke / ocular diseases / multifaceted disorders / vascular age-related macular degeneration / chronic sc-Fv fragment / malignant diseases / S. aureus / hemoglobinuria / ischemia-reperfusion injury / diseases / stitution therapy deficiency / deficiency / numerous diseases / eye diseases / inflammatory responses / inflammatory / disorders / disRheumatoid arthritis / systemic lupus erythematosus / C5a-C5aR rare diseases / hemorrhagic and septic shock / reperfusion injury / activation level Multiple sclerosis / therapy infection / single pathway Cancer / inflammation heart attack / paroxysmal nocturnal hemoglobinuria / curhereditary angioedema / Huntington’s disease / A.J. et al. The Arthus reaction / fatigue / hereditary angioedema / Alzheimer’s disease I/R injury / age-related macular degeneration / B-cell chronic lymphocytic leuke / indication disease / infections / inflammatory response Development / sepsis / blindness / autoimmune diseases / acute myocardial infarction / necrosis / rare blood disorder / disease / complement-related diseases / inflammatory / renal receptor / potent inflammatory mediators / inflammatory blood cells / infectious diseases / chronic diseases / neurodegenerative diseases / inflammation / thrombosis / computational acute rheumatoid arthritis / /

MedicalTreatment

cardiac surgery / surgery / blood transfusions / cancer therapy / bypass / lung transplants / antibiotics / chemotherapy / bypass surgery / complementary therapies / /

Organization

School of Medicine / European Union / University of Pennsylvania / European Medicines Agency / US Food and Drug Administration / Department of Pathology and Laboratory Medicine / /

Person

Peter Ward / Lev Pharma / Nat / Maciej Markiewski / Daniel Ricklin / Wenchao Song / Deborah McClellan / John D Lambris / Katie Ris-Vicari / /

Position

guard / player / /

Product

Macugen / C5 / Soliris / C5aR / HuMax-CD20 / INH / TP10 / C1-INH / PMX-53 / CD59 / braCAB-2/MLN / ARC1905 / MLN-2222 / tant drug / C1-Esterase / USA / FDA80 / C1s / alternative pathway control results / United States / PNH / C3b / /

ProvinceOrState

M.B. / Aurora / British Columbia / New York / New Jersey / Florida / /

PublishedMedium

NATURE BIOTECHNOLOGY / /

Technology

stem cells / HTML / biopharmaceuticals / drug discovery / chemotherapy / treating cancer / antibodies / biotechnology / transplantation / artificial intelligence / http / Drug design / drug development / /

URL

http /

SocialTag